# Discriminator report

## Scenario echo
The scenario is human pancreas, with celltype, age, sex, and condition unspecified, so the embedding should cover the baseline healthy human pancreatic cell landscape across endocrine, exocrine, stromal, vascular, neural, and resident immune compartments. There are no special notes altering the desired topology.

## Rating: minor
The blueprint is broadly plausible and covers the main human pancreas compartments with a reasonable mix of plain identity axes and gated subtype axes. It still has targeted coverage and marker-quality issues that should be fixed before calling it publishable.

## Findings

### Minor issues
- **immune compartment / missing dendritic-cell axis** — Healthy human pancreas contains antigen-presenting myeloid cells beyond macrophage/monocyte, including dendritic cells. The current immune branch resolves macrophage/monocyte, T, NK, B, plasma, and mast cells, but no dendritic-cell module or gated axis. This leaves DCs likely absorbed into the broad `immune_core` or `macrophage_monocyte` signal, especially because `immune_core` contains HLA/CD74 antigen-presentation genes.
  *Fix:* Add a dendritic-cell module and `dendritic_cell_within_immune` gated axis. Use canonical human DC markers such as `FCER1A`, `CLEC10A`, `CD1C`, `CD1E`, `ITGAX`, `IRF8`, `FLT3`, `CLEC9A`, `XCR1`, or `LILRA4` depending on whether the module is intended as pan-DC or split conventional/pDC; include it as a negative sibling in the existing immune gated axes.

- **epsilon_cell** — The rare epsilon-cell module is only two genes and includes `MLN`, which is much more characteristic of intestinal/gastric enteroendocrine motilin cells than canonical pancreatic epsilon cells. With only `GHRL` plus `MLN`, this axis is fragile and may score off-scope enteroendocrine contamination if present.
  *Fix:* Keep the epsilon axis if the supporting pancreas literature clearly detects it, but make the module more pancreas-specific around `GHRL` and shared endocrine/epsilon-associated markers from the cited atlases, or remove/replace `MLN` with a better-supported epsilon marker. If robust human pancreas support is weak, reduce emphasis rather than expanding with gut enteroendocrine markers.

- **immune_core** — `immune_core` mixes pan-leukocyte `PTPRC` with antigen-presentation genes (`HLA-DRA`, `HLA-DPA1`, `HLA-DPB1`, `CD74`) that are strong in B cells, macrophages, and dendritic cells but weak in many T/NK cells. As a gate, this can underweight T/NK subtype axes relative to APC-rich immune cells.
  *Fix:* Make `immune_core` more pan-leukocyte by adding broadly expressed leukocyte markers such as `LCP1`, `CORO1A`, `ARHGAP15`, `FYB1`, or `ITGAL`, and move APC-heavy genes into macrophage/DC/B modules where they carry subtype information.

- **pp_cell** — `SLC30A8` is much more associated with endocrine/beta identity than PP/gamma-cell specificity, and its reuse in both `beta_cell` and `pp_cell` weakens the contrast between beta and PP axes.
  *Fix:* Replace `SLC30A8` in `pp_cell` with a more PP/gamma-supported marker from the pancreas atlases while retaining `PPY` and `PYY` as the core signal.

## Out of scope (FYI, not actionable for the Generator)
- I did not verify paper or atlas DOI correctness; citation verification is outside this Discriminator scope.

## Summary for the next round
Preserve the overall blueprint structure, but add dendritic-cell coverage within the immune branch and tighten the rare endocrine and immune gating modules. No existing resource, module, or axis needs deletion; the needed changes are additions and marker/module edits.
